Invention Grant
US08273882B2 Quinoxaline carboxamide derivatives as protein tyrosine kinase inhibitors
有权
喹喔啉甲酰胺衍生物作为蛋白酪氨酸激酶抑制剂
- Patent Title: Quinoxaline carboxamide derivatives as protein tyrosine kinase inhibitors
- Patent Title (中): 喹喔啉甲酰胺衍生物作为蛋白酪氨酸激酶抑制剂
-
Application No.: US12470191Application Date: 2009-05-21
-
Publication No.: US08273882B2Publication Date: 2012-09-25
- Inventor: Pascal Furet , Diana Graus Porta , Vito Guagnano
- Applicant: Pascal Furet , Diana Graus Porta , Vito Guagnano
- Applicant Address: CH Basel
- Assignee: Novartis AG
- Current Assignee: Novartis AG
- Current Assignee Address: CH Basel
- Agent Laura K. Madden
- Priority: EP08156846 20080523
- Main IPC: C07D241/36
- IPC: C07D241/36
Abstract:
The invention relates to compounds of formula (I) wherein the substituents are as defined in the specification, in free form or in the form of a pharmaceutically acceptable salt, solvate, ester, N-oxide thereof; processes for the preparation thereof; to pharmaceuticals containing such compounds, in particular for the use in one or more Protein tyrosine kinase mediated diseases.
Public/Granted literature
- US20100105667A1 Quinoxaline- and Quinoline-Carboxamide Derivatives Public/Granted day:2010-04-29
Information query
